Request for Covid-19 Impact Assessment of this Report
The United States Cefepime market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Cefepime market, reaching US$ million by the year 2028. As for the Europe Cefepime landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Cefepime players cover Baxter, Apotex, B. Braun Medical, and Pfizer, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Cefepime market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Intramuscular Injection
Intravenous Drug Delivery
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Lower Respiratory Tract Infection
Urinary Tract Infection
Skin And Soft Tissue Infections
Abdominal Cavity Infection
Gynecologic Infection
Sepsis
Neutrophilic Fever
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Baxter
Apotex
B. Braun Medical
Pfizer
Perrigo
Fresenius Kabi
Sandoz (Novartis)
Piramal Critical Care
Meitheal Pharmaceuticals
BMS
Qilu Pharmaceutical
Sinopharm
Shanghai Xinfeng Pharmaceutical
Hebei Huamin Pharmaceutical
Nanjing Haichen Pharmaceutical
Shandong Luoxin Pharmaceutical Group
Guangzhou Baiyunshan Tianxin Pharmaceutical
Yuekang Pharmaceutical Group
Chengdu Beite Pharmaceutical
Jiangsu Hengrui Pharmaceutical
Hainan Star Pharmaceutical
Hainan Hailing Pharmaceutical
Shenzhen Xinlitai Pharmaceutical
Shenzhen Lijian Pharmaceutical
Suzhou Dongrui Pharmaceutical
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cefepime Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Cefepime by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Cefepime by Country/Region, 2017, 2022 & 2028
2.2 Cefepime Segment by Type
2.2.1 Intramuscular Injection
2.2.2 Intravenous Drug Delivery
2.3 Cefepime Sales by Type
2.3.1 Global Cefepime Sales Market Share by Type (2017-2022)
2.3.2 Global Cefepime Revenue and Market Share by Type (2017-2022)
2.3.3 Global Cefepime Sale Price by Type (2017-2022)
2.4 Cefepime Segment by Application
2.4.1 Lower Respiratory Tract Infection
2.4.2 Urinary Tract Infection
2.4.3 Skin And Soft Tissue Infections
2.4.4 Abdominal Cavity Infection
2.4.5 Gynecologic Infection
2.4.6 Sepsis
2.4.7 Neutrophilic Fever
2.5 Cefepime Sales by Application
2.5.1 Global Cefepime Sale Market Share by Application (2017-2022)
2.5.2 Global Cefepime Revenue and Market Share by Application (2017-2022)
2.5.3 Global Cefepime Sale Price by Application (2017-2022)
3 Global Cefepime by Company
3.1 Global Cefepime Breakdown Data by Company
3.1.1 Global Cefepime Annual Sales by Company (2020-2022)
3.1.2 Global Cefepime Sales Market Share by Company (2020-2022)
3.2 Global Cefepime Annual Revenue by Company (2020-2022)
3.2.1 Global Cefepime Revenue by Company (2020-2022)
3.2.2 Global Cefepime Revenue Market Share by Company (2020-2022)
3.3 Global Cefepime Sale Price by Company
3.4 Key Manufacturers Cefepime Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cefepime Product Location Distribution
3.4.2 Players Cefepime Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Cefepime by Geographic Region
4.1 World Historic Cefepime Market Size by Geographic Region (2017-2022)
4.1.1 Global Cefepime Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Cefepime Annual Revenue by Geographic Region
4.2 World Historic Cefepime Market Size by Country/Region (2017-2022)
4.2.1 Global Cefepime Annual Sales by Country/Region (2017-2022)
4.2.2 Global Cefepime Annual Revenue by Country/Region
4.3 Americas Cefepime Sales Growth
4.4 APAC Cefepime Sales Growth
4.5 Europe Cefepime Sales Growth
4.6 Middle East & Africa Cefepime Sales Growth
5 Americas
5.1 Americas Cefepime Sales by Country
5.1.1 Americas Cefepime Sales by Country (2017-2022)
5.1.2 Americas Cefepime Revenue by Country (2017-2022)
5.2 Americas Cefepime Sales by Type
5.3 Americas Cefepime Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cefepime Sales by Region
6.1.1 APAC Cefepime Sales by Region (2017-2022)
6.1.2 APAC Cefepime Revenue by Region (2017-2022)
6.2 APAC Cefepime Sales by Type
6.3 APAC Cefepime Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Cefepime by Country
7.1.1 Europe Cefepime Sales by Country (2017-2022)
7.1.2 Europe Cefepime Revenue by Country (2017-2022)
7.2 Europe Cefepime Sales by Type
7.3 Europe Cefepime Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cefepime by Country
8.1.1 Middle East & Africa Cefepime Sales by Country (2017-2022)
8.1.2 Middle East & Africa Cefepime Revenue by Country (2017-2022)
8.2 Middle East & Africa Cefepime Sales by Type
8.3 Middle East & Africa Cefepime Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Cefepime
10.3 Manufacturing Process Analysis of Cefepime
10.4 Industry Chain Structure of Cefepime
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Cefepime Distributors
11.3 Cefepime Customer
12 World Forecast Review for Cefepime by Geographic Region
12.1 Global Cefepime Market Size Forecast by Region
12.1.1 Global Cefepime Forecast by Region (2023-2028)
12.1.2 Global Cefepime Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Cefepime Forecast by Type
12.7 Global Cefepime Forecast by Application
13 Key Players Analysis
13.1 Baxter
13.1.1 Baxter Company Information
13.1.2 Baxter Cefepime Product Offered
13.1.3 Baxter Cefepime Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Baxter Main Business Overview
13.1.5 Baxter Latest Developments
13.2 Apotex
13.2.1 Apotex Company Information
13.2.2 Apotex Cefepime Product Offered
13.2.3 Apotex Cefepime Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Apotex Main Business Overview
13.2.5 Apotex Latest Developments
13.3 B. Braun Medical
13.3.1 B. Braun Medical Company Information
13.3.2 B. Braun Medical Cefepime Product Offered
13.3.3 B. Braun Medical Cefepime Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 B. Braun Medical Main Business Overview
13.3.5 B. Braun Medical Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Cefepime Product Offered
13.4.3 Pfizer Cefepime Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Perrigo
13.5.1 Perrigo Company Information
13.5.2 Perrigo Cefepime Product Offered
13.5.3 Perrigo Cefepime Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Perrigo Main Business Overview
13.5.5 Perrigo Latest Developments
13.6 Fresenius Kabi
13.6.1 Fresenius Kabi Company Information
13.6.2 Fresenius Kabi Cefepime Product Offered
13.6.3 Fresenius Kabi Cefepime Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Fresenius Kabi Main Business Overview
13.6.5 Fresenius Kabi Latest Developments
13.7 Sandoz (Novartis)
13.7.1 Sandoz (Novartis) Company Information
13.7.2 Sandoz (Novartis) Cefepime Product Offered
13.7.3 Sandoz (Novartis) Cefepime Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Sandoz (Novartis) Main Business Overview
13.7.5 Sandoz (Novartis) Latest Developments
13.8 Piramal Critical Care
13.8.1 Piramal Critical Care Company Information
13.8.2 Piramal Critical Care Cefepime Product Offered
13.8.3 Piramal Critical Care Cefepime Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Piramal Critical Care Main Business Overview
13.8.5 Piramal Critical Care Latest Developments
13.9 Meitheal Pharmaceuticals
13.9.1 Meitheal Pharmaceuticals Company Information
13.9.2 Meitheal Pharmaceuticals Cefepime Product Offered
13.9.3 Meitheal Pharmaceuticals Cefepime Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Meitheal Pharmaceuticals Main Business Overview
13.9.5 Meitheal Pharmaceuticals Latest Developments
13.10 BMS
13.10.1 BMS Company Information
13.10.2 BMS Cefepime Product Offered
13.10.3 BMS Cefepime Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 BMS Main Business Overview
13.10.5 BMS Latest Developments
13.11 Qilu Pharmaceutical
13.11.1 Qilu Pharmaceutical Company Information
13.11.2 Qilu Pharmaceutical Cefepime Product Offered
13.11.3 Qilu Pharmaceutical Cefepime Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Qilu Pharmaceutical Main Business Overview
13.11.5 Qilu Pharmaceutical Latest Developments
13.12 Sinopharm
13.12.1 Sinopharm Company Information
13.12.2 Sinopharm Cefepime Product Offered
13.12.3 Sinopharm Cefepime Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Sinopharm Main Business Overview
13.12.5 Sinopharm Latest Developments
13.13 Shanghai Xinfeng Pharmaceutical
13.13.1 Shanghai Xinfeng Pharmaceutical Company Information
13.13.2 Shanghai Xinfeng Pharmaceutical Cefepime Product Offered
13.13.3 Shanghai Xinfeng Pharmaceutical Cefepime Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Shanghai Xinfeng Pharmaceutical Main Business Overview
13.13.5 Shanghai Xinfeng Pharmaceutical Latest Developments
13.14 Hebei Huamin Pharmaceutical
13.14.1 Hebei Huamin Pharmaceutical Company Information
13.14.2 Hebei Huamin Pharmaceutical Cefepime Product Offered
13.14.3 Hebei Huamin Pharmaceutical Cefepime Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Hebei Huamin Pharmaceutical Main Business Overview
13.14.5 Hebei Huamin Pharmaceutical Latest Developments
13.15 Nanjing Haichen Pharmaceutical
13.15.1 Nanjing Haichen Pharmaceutical Company Information
13.15.2 Nanjing Haichen Pharmaceutical Cefepime Product Offered
13.15.3 Nanjing Haichen Pharmaceutical Cefepime Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Nanjing Haichen Pharmaceutical Main Business Overview
13.15.5 Nanjing Haichen Pharmaceutical Latest Developments
13.16 Shandong Luoxin Pharmaceutical Group
13.16.1 Shandong Luoxin Pharmaceutical Group Company Information
13.16.2 Shandong Luoxin Pharmaceutical Group Cefepime Product Offered
13.16.3 Shandong Luoxin Pharmaceutical Group Cefepime Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Shandong Luoxin Pharmaceutical Group Main Business Overview
13.16.5 Shandong Luoxin Pharmaceutical Group Latest Developments
13.17 Guangzhou Baiyunshan Tianxin Pharmaceutical
13.17.1 Guangzhou Baiyunshan Tianxin Pharmaceutical Company Information
13.17.2 Guangzhou Baiyunshan Tianxin Pharmaceutical Cefepime Product Offered
13.17.3 Guangzhou Baiyunshan Tianxin Pharmaceutical Cefepime Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Guangzhou Baiyunshan Tianxin Pharmaceutical Main Business Overview
13.17.5 Guangzhou Baiyunshan Tianxin Pharmaceutical Latest Developments
13.18 Yuekang Pharmaceutical Group
13.18.1 Yuekang Pharmaceutical Group Company Information
13.18.2 Yuekang Pharmaceutical Group Cefepime Product Offered
13.18.3 Yuekang Pharmaceutical Group Cefepime Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Yuekang Pharmaceutical Group Main Business Overview
13.18.5 Yuekang Pharmaceutical Group Latest Developments
13.19 Chengdu Beite Pharmaceutical
13.19.1 Chengdu Beite Pharmaceutical Company Information
13.19.2 Chengdu Beite Pharmaceutical Cefepime Product Offered
13.19.3 Chengdu Beite Pharmaceutical Cefepime Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 Chengdu Beite Pharmaceutical Main Business Overview
13.19.5 Chengdu Beite Pharmaceutical Latest Developments
13.20 Jiangsu Hengrui Pharmaceutical
13.20.1 Jiangsu Hengrui Pharmaceutical Company Information
13.20.2 Jiangsu Hengrui Pharmaceutical Cefepime Product Offered
13.20.3 Jiangsu Hengrui Pharmaceutical Cefepime Sales, Revenue, Price and Gross Margin (2020-2022)
13.20.4 Jiangsu Hengrui Pharmaceutical Main Business Overview
13.20.5 Jiangsu Hengrui Pharmaceutical Latest Developments
13.21 Hainan Star Pharmaceutical
13.21.1 Hainan Star Pharmaceutical Company Information
13.21.2 Hainan Star Pharmaceutical Cefepime Product Offered
13.21.3 Hainan Star Pharmaceutical Cefepime Sales, Revenue, Price and Gross Margin (2020-2022)
13.21.4 Hainan Star Pharmaceutical Main Business Overview
13.21.5 Hainan Star Pharmaceutical Latest Developments
13.22 Hainan Hailing Pharmaceutical
13.22.1 Hainan Hailing Pharmaceutical Company Information
13.22.2 Hainan Hailing Pharmaceutical Cefepime Product Offered
13.22.3 Hainan Hailing Pharmaceutical Cefepime Sales, Revenue, Price and Gross Margin (2020-2022)
13.22.4 Hainan Hailing Pharmaceutical Main Business Overview
13.22.5 Hainan Hailing Pharmaceutical Latest Developments
13.23 Shenzhen Xinlitai Pharmaceutical
13.23.1 Shenzhen Xinlitai Pharmaceutical Company Information
13.23.2 Shenzhen Xinlitai Pharmaceutical Cefepime Product Offered
13.23.3 Shenzhen Xinlitai Pharmaceutical Cefepime Sales, Revenue, Price and Gross Margin (2020-2022)
13.23.4 Shenzhen Xinlitai Pharmaceutical Main Business Overview
13.23.5 Shenzhen Xinlitai Pharmaceutical Latest Developments
13.24 Shenzhen Lijian Pharmaceutical
13.24.1 Shenzhen Lijian Pharmaceutical Company Information
13.24.2 Shenzhen Lijian Pharmaceutical Cefepime Product Offered
13.24.3 Shenzhen Lijian Pharmaceutical Cefepime Sales, Revenue, Price and Gross Margin (2020-2022)
13.24.4 Shenzhen Lijian Pharmaceutical Main Business Overview
13.24.5 Shenzhen Lijian Pharmaceutical Latest Developments
13.25 Suzhou Dongrui Pharmaceutical
13.25.1 Suzhou Dongrui Pharmaceutical Company Information
13.25.2 Suzhou Dongrui Pharmaceutical Cefepime Product Offered
13.25.3 Suzhou Dongrui Pharmaceutical Cefepime Sales, Revenue, Price and Gross Margin (2020-2022)
13.25.4 Suzhou Dongrui Pharmaceutical Main Business Overview
13.25.5 Suzhou Dongrui Pharmaceutical Latest Developments
14 Research Findings and Conclusion
Table 1. Cefepime Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Cefepime Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Intramuscular Injection
Table 4. Major Players of Intravenous Drug Delivery
Table 5. Global Cefepime Sales by Type (2017-2022) & (K Units)
Table 6. Global Cefepime Sales Market Share by Type (2017-2022)
Table 7. Global Cefepime Revenue by Type (2017-2022) & ($ million)
Table 8. Global Cefepime Revenue Market Share by Type (2017-2022)
Table 9. Global Cefepime Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Cefepime Sales by Application (2017-2022) & (K Units)
Table 11. Global Cefepime Sales Market Share by Application (2017-2022)
Table 12. Global Cefepime Revenue by Application (2017-2022)
Table 13. Global Cefepime Revenue Market Share by Application (2017-2022)
Table 14. Global Cefepime Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Cefepime Sales by Company (2020-2022) & (K Units)
Table 16. Global Cefepime Sales Market Share by Company (2020-2022)
Table 17. Global Cefepime Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Cefepime Revenue Market Share by Company (2020-2022)
Table 19. Global Cefepime Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Cefepime Producing Area Distribution and Sales Area
Table 21. Players Cefepime Products Offered
Table 22. Cefepime Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Cefepime Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Cefepime Sales Market Share Geographic Region (2017-2022)
Table 27. Global Cefepime Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Cefepime Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Cefepime Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Cefepime Sales Market Share by Country/Region (2017-2022)
Table 31. Global Cefepime Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Cefepime Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Cefepime Sales by Country (2017-2022) & (K Units)
Table 34. Americas Cefepime Sales Market Share by Country (2017-2022)
Table 35. Americas Cefepime Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Cefepime Revenue Market Share by Country (2017-2022)
Table 37. Americas Cefepime Sales by Type (2017-2022) & (K Units)
Table 38. Americas Cefepime Sales Market Share by Type (2017-2022)
Table 39. Americas Cefepime Sales by Application (2017-2022) & (K Units)
Table 40. Americas Cefepime Sales Market Share by Application (2017-2022)
Table 41. APAC Cefepime Sales by Region (2017-2022) & (K Units)
Table 42. APAC Cefepime Sales Market Share by Region (2017-2022)
Table 43. APAC Cefepime Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Cefepime Revenue Market Share by Region (2017-2022)
Table 45. APAC Cefepime Sales by Type (2017-2022) & (K Units)
Table 46. APAC Cefepime Sales Market Share by Type (2017-2022)
Table 47. APAC Cefepime Sales by Application (2017-2022) & (K Units)
Table 48. APAC Cefepime Sales Market Share by Application (2017-2022)
Table 49. Europe Cefepime Sales by Country (2017-2022) & (K Units)
Table 50. Europe Cefepime Sales Market Share by Country (2017-2022)
Table 51. Europe Cefepime Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Cefepime Revenue Market Share by Country (2017-2022)
Table 53. Europe Cefepime Sales by Type (2017-2022) & (K Units)
Table 54. Europe Cefepime Sales Market Share by Type (2017-2022)
Table 55. Europe Cefepime Sales by Application (2017-2022) & (K Units)
Table 56. Europe Cefepime Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Cefepime Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Cefepime Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Cefepime Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Cefepime Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Cefepime Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Cefepime Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Cefepime Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Cefepime Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Cefepime
Table 66. Key Market Challenges & Risks of Cefepime
Table 67. Key Industry Trends of Cefepime
Table 68. Cefepime Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Cefepime Distributors List
Table 71. Cefepime Customer List
Table 72. Global Cefepime Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Cefepime Sales Market Forecast by Region
Table 74. Global Cefepime Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Cefepime Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Cefepime Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Cefepime Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Cefepime Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Cefepime Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Cefepime Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Cefepime Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Cefepime Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Cefepime Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Cefepime Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Cefepime Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Cefepime Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Cefepime Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Cefepime Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Cefepime Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Cefepime Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Cefepime Revenue Market Share Forecast by Application (2023-2028)
Table 92. Baxter Basic Information, Cefepime Manufacturing Base, Sales Area and Its Competitors
Table 93. Baxter Cefepime Product Offered
Table 94. Baxter Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Baxter Main Business
Table 96. Baxter Latest Developments
Table 97. Apotex Basic Information, Cefepime Manufacturing Base, Sales Area and Its Competitors
Table 98. Apotex Cefepime Product Offered
Table 99. Apotex Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Apotex Main Business
Table 101. Apotex Latest Developments
Table 102. B. Braun Medical Basic Information, Cefepime Manufacturing Base, Sales Area and Its Competitors
Table 103. B. Braun Medical Cefepime Product Offered
Table 104. B. Braun Medical Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. B. Braun Medical Main Business
Table 106. B. Braun Medical Latest Developments
Table 107. Pfizer Basic Information, Cefepime Manufacturing Base, Sales Area and Its Competitors
Table 108. Pfizer Cefepime Product Offered
Table 109. Pfizer Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Pfizer Main Business
Table 111. Pfizer Latest Developments
Table 112. Perrigo Basic Information, Cefepime Manufacturing Base, Sales Area and Its Competitors
Table 113. Perrigo Cefepime Product Offered
Table 114. Perrigo Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Perrigo Main Business
Table 116. Perrigo Latest Developments
Table 117. Fresenius Kabi Basic Information, Cefepime Manufacturing Base, Sales Area and Its Competitors
Table 118. Fresenius Kabi Cefepime Product Offered
Table 119. Fresenius Kabi Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Fresenius Kabi Main Business
Table 121. Fresenius Kabi Latest Developments
Table 122. Sandoz (Novartis) Basic Information, Cefepime Manufacturing Base, Sales Area and Its Competitors
Table 123. Sandoz (Novartis) Cefepime Product Offered
Table 124. Sandoz (Novartis) Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Sandoz (Novartis) Main Business
Table 126. Sandoz (Novartis) Latest Developments
Table 127. Piramal Critical Care Basic Information, Cefepime Manufacturing Base, Sales Area and Its Competitors
Table 128. Piramal Critical Care Cefepime Product Offered
Table 129. Piramal Critical Care Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Piramal Critical Care Main Business
Table 131. Piramal Critical Care Latest Developments
Table 132. Meitheal Pharmaceuticals Basic Information, Cefepime Manufacturing Base, Sales Area and Its Competitors
Table 133. Meitheal Pharmaceuticals Cefepime Product Offered
Table 134. Meitheal Pharmaceuticals Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Meitheal Pharmaceuticals Main Business
Table 136. Meitheal Pharmaceuticals Latest Developments
Table 137. BMS Basic Information, Cefepime Manufacturing Base, Sales Area and Its Competitors
Table 138. BMS Cefepime Product Offered
Table 139. BMS Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. BMS Main Business
Table 141. BMS Latest Developments
Table 142. Qilu Pharmaceutical Basic Information, Cefepime Manufacturing Base, Sales Area and Its Competitors
Table 143. Qilu Pharmaceutical Cefepime Product Offered
Table 144. Qilu Pharmaceutical Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. Qilu Pharmaceutical Main Business
Table 146. Qilu Pharmaceutical Latest Developments
Table 147. Sinopharm Basic Information, Cefepime Manufacturing Base, Sales Area and Its Competitors
Table 148. Sinopharm Cefepime Product Offered
Table 149. Sinopharm Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 150. Sinopharm Main Business
Table 151. Sinopharm Latest Developments
Table 152. Shanghai Xinfeng Pharmaceutical Basic Information, Cefepime Manufacturing Base, Sales Area and Its Competitors
Table 153. Shanghai Xinfeng Pharmaceutical Cefepime Product Offered
Table 154. Shanghai Xinfeng Pharmaceutical Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 155. Shanghai Xinfeng Pharmaceutical Main Business
Table 156. Shanghai Xinfeng Pharmaceutical Latest Developments
Table 157. Hebei Huamin Pharmaceutical Basic Information, Cefepime Manufacturing Base, Sales Area and Its Competitors
Table 158. Hebei Huamin Pharmaceutical Cefepime Product Offered
Table 159. Hebei Huamin Pharmaceutical Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 160. Hebei Huamin Pharmaceutical Main Business
Table 161. Hebei Huamin Pharmaceutical Latest Developments
Table 162. Nanjing Haichen Pharmaceutical Basic Information, Cefepime Manufacturing Base, Sales Area and Its Competitors
Table 163. Nanjing Haichen Pharmaceutical Cefepime Product Offered
Table 164. Nanjing Haichen Pharmaceutical Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 165. Nanjing Haichen Pharmaceutical Main Business
Table 166. Nanjing Haichen Pharmaceutical Latest Developments
Table 167. Shandong Luoxin Pharmaceutical Group Basic Information, Cefepime Manufacturing Base, Sales Area and Its Competitors
Table 168. Shandong Luoxin Pharmaceutical Group Cefepime Product Offered
Table 169. Shandong Luoxin Pharmaceutical Group Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 170. Shandong Luoxin Pharmaceutical Group Main Business
Table 171. Shandong Luoxin Pharmaceutical Group Latest Developments
Table 172. Guangzhou Baiyunshan Tianxin Pharmaceutical Basic Information, Cefepime Manufacturing Base, Sales Area and Its Competitors
Table 173. Guangzhou Baiyunshan Tianxin Pharmaceutical Cefepime Product Offered
Table 174. Guangzhou Baiyunshan Tianxin Pharmaceutical Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 175. Guangzhou Baiyunshan Tianxin Pharmaceutical Main Business
Table 176. Guangzhou Baiyunshan Tianxin Pharmaceutical Latest Developments
Table 177. Yuekang Pharmaceutical Group Basic Information, Cefepime Manufacturing Base, Sales Area and Its Competitors
Table 178. Yuekang Pharmaceutical Group Cefepime Product Offered
Table 179. Yuekang Pharmaceutical Group Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 180. Yuekang Pharmaceutical Group Main Business
Table 181. Yuekang Pharmaceutical Group Latest Developments
Table 182. Chengdu Beite Pharmaceutical Basic Information, Cefepime Manufacturing Base, Sales Area and Its Competitors
Table 183. Chengdu Beite Pharmaceutical Cefepime Product Offered
Table 184. Chengdu Beite Pharmaceutical Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 185. Chengdu Beite Pharmaceutical Main Business
Table 186. Chengdu Beite Pharmaceutical Latest Developments
Table 187. Jiangsu Hengrui Pharmaceutical Basic Information, Cefepime Manufacturing Base, Sales Area and Its Competitors
Table 188. Jiangsu Hengrui Pharmaceutical Cefepime Product Offered
Table 189. Jiangsu Hengrui Pharmaceutical Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 190. Jiangsu Hengrui Pharmaceutical Main Business
Table 191. Jiangsu Hengrui Pharmaceutical Latest Developments
Table 192. Hainan Star Pharmaceutical Basic Information, Cefepime Manufacturing Base, Sales Area and Its Competitors
Table 193. Hainan Star Pharmaceutical Cefepime Product Offered
Table 194. Hainan Star Pharmaceutical Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 195. Hainan Star Pharmaceutical Main Business
Table 196. Hainan Star Pharmaceutical Latest Developments
Table 197. Hainan Hailing Pharmaceutical Basic Information, Cefepime Manufacturing Base, Sales Area and Its Competitors
Table 198. Hainan Hailing Pharmaceutical Cefepime Product Offered
Table 199. Hainan Hailing Pharmaceutical Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 200. Hainan Hailing Pharmaceutical Main Business
Table 201. Hainan Hailing Pharmaceutical Latest Developments
Table 202. Shenzhen Xinlitai Pharmaceutical Basic Information, Cefepime Manufacturing Base, Sales Area and Its Competitors
Table 203. Shenzhen Xinlitai Pharmaceutical Cefepime Product Offered
Table 204. Shenzhen Xinlitai Pharmaceutical Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 205. Shenzhen Xinlitai Pharmaceutical Main Business
Table 206. Shenzhen Xinlitai Pharmaceutical Latest Developments
Table 207. Shenzhen Lijian Pharmaceutical Basic Information, Cefepime Manufacturing Base, Sales Area and Its Competitors
Table 208. Shenzhen Lijian Pharmaceutical Cefepime Product Offered
Table 209. Shenzhen Lijian Pharmaceutical Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 210. Shenzhen Lijian Pharmaceutical Main Business
Table 211. Shenzhen Lijian Pharmaceutical Latest Developments
Table 212. Suzhou Dongrui Pharmaceutical Basic Information, Cefepime Manufacturing Base, Sales Area and Its Competitors
Table 213. Suzhou Dongrui Pharmaceutical Cefepime Product Offered
Table 214. Suzhou Dongrui Pharmaceutical Cefepime Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 215. Suzhou Dongrui Pharmaceutical Main Business
Table 216. Suzhou Dongrui Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Cefepime
Figure 2. Cefepime Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Cefepime Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Cefepime Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Cefepime Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Intramuscular Injection
Figure 10. Product Picture of Intravenous Drug Delivery
Figure 11. Global Cefepime Sales Market Share by Type in 2021
Figure 12. Global Cefepime Revenue Market Share by Type (2017-2022)
Figure 13. Cefepime Consumed in Lower Respiratory Tract Infection
Figure 14. Global Cefepime Market: Lower Respiratory Tract Infection (2017-2022) & (K Units)
Figure 15. Cefepime Consumed in Urinary Tract Infection
Figure 16. Global Cefepime Market: Urinary Tract Infection (2017-2022) & (K Units)
Figure 17. Cefepime Consumed in Skin And Soft Tissue Infections
Figure 18. Global Cefepime Market: Skin And Soft Tissue Infections (2017-2022) & (K Units)
Figure 19. Cefepime Consumed in Abdominal Cavity Infection
Figure 20. Global Cefepime Market: Abdominal Cavity Infection (2017-2022) & (K Units)
Figure 21. Cefepime Consumed in Gynecologic Infection
Figure 22. Global Cefepime Market: Gynecologic Infection (2017-2022) & (K Units)
Figure 23. Cefepime Consumed in Sepsis
Figure 24. Global Cefepime Market: Sepsis (2017-2022) & (K Units)
Figure 25. Cefepime Consumed in Neutrophilic Fever
Figure 26. Global Cefepime Market: Neutrophilic Fever (2017-2022) & (K Units)
Figure 27. Global Cefepime Sales Market Share by Application (2017-2022)
Figure 28. Global Cefepime Revenue Market Share by Application in 2021
Figure 29. Cefepime Revenue Market by Company in 2021 ($ Million)
Figure 30. Global Cefepime Revenue Market Share by Company in 2021
Figure 31. Global Cefepime Sales Market Share by Geographic Region (2017-2022)
Figure 32. Global Cefepime Revenue Market Share by Geographic Region in 2021
Figure 33. Global Cefepime Sales Market Share by Region (2017-2022)
Figure 34. Global Cefepime Revenue Market Share by Country/Region in 2021
Figure 35. Americas Cefepime Sales 2017-2022 (K Units)
Figure 36. Americas Cefepime Revenue 2017-2022 ($ Millions)
Figure 37. APAC Cefepime Sales 2017-2022 (K Units)
Figure 38. APAC Cefepime Revenue 2017-2022 ($ Millions)
Figure 39. Europe Cefepime Sales 2017-2022 (K Units)
Figure 40. Europe Cefepime Revenue 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Cefepime Sales 2017-2022 (K Units)
Figure 42. Middle East & Africa Cefepime Revenue 2017-2022 ($ Millions)
Figure 43. Americas Cefepime Sales Market Share by Country in 2021
Figure 44. Americas Cefepime Revenue Market Share by Country in 2021
Figure 45. United States Cefepime Revenue Growth 2017-2022 ($ Millions)
Figure 46. Canada Cefepime Revenue Growth 2017-2022 ($ Millions)
Figure 47. Mexico Cefepime Revenue Growth 2017-2022 ($ Millions)
Figure 48. Brazil Cefepime Revenue Growth 2017-2022 ($ Millions)
Figure 49. APAC Cefepime Sales Market Share by Region in 2021
Figure 50. APAC Cefepime Revenue Market Share by Regions in 2021
Figure 51. China Cefepime Revenue Growth 2017-2022 ($ Millions)
Figure 52. Japan Cefepime Revenue Growth 2017-2022 ($ Millions)
Figure 53. South Korea Cefepime Revenue Growth 2017-2022 ($ Millions)
Figure 54. Southeast Asia Cefepime Revenue Growth 2017-2022 ($ Millions)
Figure 55. India Cefepime Revenue Growth 2017-2022 ($ Millions)
Figure 56. Australia Cefepime Revenue Growth 2017-2022 ($ Millions)
Figure 57. Europe Cefepime Sales Market Share by Country in 2021
Figure 58. Europe Cefepime Revenue Market Share by Country in 2021
Figure 59. Germany Cefepime Revenue Growth 2017-2022 ($ Millions)
Figure 60. France Cefepime Revenue Growth 2017-2022 ($ Millions)
Figure 61. UK Cefepime Revenue Growth 2017-2022 ($ Millions)
Figure 62. Italy Cefepime Revenue Growth 2017-2022 ($ Millions)
Figure 63. Russia Cefepime Revenue Growth 2017-2022 ($ Millions)
Figure 64. Middle East & Africa Cefepime Sales Market Share by Country in 2021
Figure 65. Middle East & Africa Cefepime Revenue Market Share by Country in 2021
Figure 66. Egypt Cefepime Revenue Growth 2017-2022 ($ Millions)
Figure 67. South Africa Cefepime Revenue Growth 2017-2022 ($ Millions)
Figure 68. Israel Cefepime Revenue Growth 2017-2022 ($ Millions)
Figure 69. Turkey Cefepime Revenue Growth 2017-2022 ($ Millions)
Figure 70. GCC Country Cefepime Revenue Growth 2017-2022 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Cefepime in 2021
Figure 72. Manufacturing Process Analysis of Cefepime
Figure 73. Industry Chain Structure of Cefepime
Figure 74. Channels of Distribution
Figure 75. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...